ALN OATF Vena Cava Filter (CONFIAL)

Assistance Publique - Hôpitaux de Paris

Status: Enrolling

Conditions: Pulmonary Embolism

Treatments: Device: Filter implantation

Study type: Observational

Funder types: Other

Identifiers

NCT05785676

2022-A00915-38 (Other Identifier)

APHP220570

Details and patient eligibility

About

Migration of a thrombus in the pulmonary circulation is the leading cause of pulmonary embolism (PE). It can be prevented mechanically by implanting a vena cava filter (VCF) in the inferior vena cava. The implation of a VCF is indicated for patients with acute PE and a contraindication to anticoagulation, with an acute deep vein thrombosis (DVT) without PE and a contraindication to anticoagulation or with acute venous thromboembolism (less than 3 months) in whom an interventional gesture at hemorrhagic and thromboembolic risk contraindicates anticoagulation.

The purpose of this study is to describe the rates of implantation, removal and complications associated with the use of the optional ALN OATF VCF in current practice.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient implanted with an ALN OATF VCF
• Patient informed

Exclusion criteria

• Minor patient
• Adult patient under a legal protection measure
• Pregnant, parturient or breastfeeding women
• Patient who refused to participate
• Patient who cannot or does not wish to be followed by the Interventional Radiology Department

Trial design

50 participants in 1 patient group

Vena Cava Filter

Description:

Participants implanted with the vena cava filter OATF (ALN)

Treatment:

Device: Filter implantation